drugset / Trial / NCT01423305
Phase I Pharmacokinetic Study (BF-BLOCK)
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of the study is to assess if charcoal prevents the absorption of budesonide and formoterol via GI track. The assessment will be based on comparing the pharmacokinetic parameter area under the concentration-time curve.
Timeline
- Start
- 2011-08
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | — | Oral |
| Subject | Formoterol | Other / unclassified | — | Oral |